📰 Statistical Analysis Plan News
Page 2 - Statistical Analysis Plan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statistical Analysis Plan. Real-time updates on events, politics, business and more.
November 22, 2022
JERSEY CITY, N.J., Nov. 22, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Clinical Trial Planning and Design Services Market
November 22, 2022
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Clinical Trial Planning and Design Services Market...
November 17, 2022
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
November 17, 2022
Both Median Survival and Long Tail of Extended Survival Were Increased In Both Newly Diagnosed and Recurrent GlioblastomaResults Featured In JAM...
August 23, 2022
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
July 27, 2022
FDA issues guidance and recommendations for New Drug Applications (NDA) and Biologic Laboratory Applications (BLA) which implicate oncology therapies and warrant Real-time Oncology Review (RTOR).
June 23, 2022
Shiraz Badurdeen and colleagues evaluate whether physiologically-based cord clamping provides physiological benefits over early cord clamping for infants requiring resuscitation at birth.
May 9, 2022
Mereo BioPharma announces Positive Top-Line Efficacy and Safety Data from “ASTRAEUS” Phase 2 Trial of Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Emphysema - read this article along with other careers information, tips and advice on BioSpace
April 20, 2022
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the...